Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase

AAPS PharmSci

Volumn 2, Issue 1, 2000, Pages 1-10

  Maurer, Tristan S ^a   Fung, Ho Leung ^a   Otsuka, Makoto ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NG NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ALGORITHM; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL LINE; COMPARATIVE STUDY; KINETICS; METABOLISM; MOUSE; NONLINEAR SYSTEM;

ALGORITHMS; ANIMAL; CELL LINE; COMPARATIVE STUDY; ENZYME INHIBITORS; KINETICS; MICE; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC-OXIDE SYNTHASE; NONLINEAR DYNAMICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 33947235192     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cheng Y, Prusoff WH. Relationship between the inhibition constant KI and the concentration of inhibitor which causes 50 per cent inhibition 150 of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
2. Furfine ES, Harmon MF, Paith JE, Knowles, RG, Salter M, Kiff, RJ, et al. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem. 1994;269:26677-26683.
3. Garvey EP, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, et al. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem. 1994;269:26669-26676.
4. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997;272:4959-4963.
5. Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet. 1997;32:210-258.
6. Ghosh SS, Said-Nejad O, Roestamadji J, Mobashery S. The first mechanism-based inactivators for angiotensin-converting enzyme. J Med Chem. 1992;35:4175-4179.
7. Kalgutkar AS, Castagnoli Jr N. Synthesis of novel MPTP analogs as potential monoamine oxidase B MAO-B inhibitors. J Med Chem. 1992;35:4165-4174.
8. Wade ML, Voelkel NF, Fitzpatrick FA. "Suicide" inactivation of prostaglandin 12 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch Biochem Biophys. 1995;321:453-458.
9. Wolff DJ, Gauld DS, Neulander MJ, Southan G. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas. J Pharmacol Exp Ther. 1997;283:265-273.
10. Marks GS, McCluskey SA, Mackie JE, Riddick DS, James CA. Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. FASEB J. 1988;2:2774-2783.
11. Bondon A, Macdonald TL, Harris TM, Guengerich FP. Oxidation of cycloalkylamines by cytochrome P-450. Mechanism-based inactivation, adduct formation, ring expansion, and nitrone formation. J Biol Chem. 1989;264:1988-1997.
12. Rando RR. Mechanism-based enzyme inactivators. Pharmacol Rev. 1984;36:111-142.
13. Rando RR. Chemistry and enzymology of kcat inhibitors. Science. 1974;85:320-324.
14. Palfreyman MG, Bey P, Sjoerdsma A. Enzyme-activated/mechanism-based inhibitors. Essays Biochem. 1987;23:28-81.
15. Chen PF, Tsai AL, Wu KK. Cysteine 99 of endothelial nitric oxide synthase NOS-III is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Comm. 1995;215:1119-1129.
16. Kitz R, Wilson IB. Esters of methanesulfonic acid as irreversible inhibitors of Acetylcholinesterase. J Biol Chem. 1962;237:3245-3249.
17. Dixon M. The determination of enzyme inhibitor constants. Biochem J. 1952;55:170-171.
18. Silverman R. Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology. Boca Raton, FL: CRC Press; 1988.
19. Reif DW, McCreedy SA. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch Biochem Biophys. 1995;320:170-176.
20. Olken NM, Marietta MA. NG-allyl- and NG-cyclopropyl-L-arginine: two novel inhibitors of macrophage nitric oxide synthase. J Med Chem. 1992;35:1137-1144.
21. Olken NM, Rusche KM, Richards MK, Marletta MA. Inactivation of macrophage nitric oxide synthase activity by NG-methyl-L-arginine. Biochem Biophys Res Comm. 1991;177:828-833.
22. Boje KM, Fung HL. Endothelial nitric oxide generating enzymes in the bovine aorta: subcellular location and metabolic characterization. J Pharmacol Exp Ther. 1990;253:20-26.
23. Motulsky HJ, Ransnas LA. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1987;1:365-374.
24. Olken NM, Marietta MA. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry. 1993;32:9677-9685.